Search

Your search keyword '"Treiber, Daniel"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Treiber, Daniel" Remove constraint Author: "Treiber, Daniel"
118 results on '"Treiber, Daniel"'

Search Results

1. Inhibition of Drug-Resistant Mutants of ABL, KIT, and EGF Receptor Kinases

2. 9. “BIGNESS” & EURALILLE (1989–1998): I KNEW I WAS IN TROUBLE BUT I THOUGHT I WAS IN HELL

5. Management of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Onboard a U.S. Navy Hospital Ship Amid a Global Omicron Surge

8. Forschungsbericht 2012

11. The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification

17. The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification

19. Donated chemical probes for open science

20. Author response: Donated chemical probes for open science

21. Progress towards a public chemogenomic set for protein kinases and a call for contributions

22. Progress towards a public chemogenomic set for protein kinases and a call for contributions

23. Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit

26. Abstract 5387: Dual kinase/bromodomain inhibitors for rationally designed polypharmacology

27. Erratum: Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

28. Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

30. Abstract 4238: BROMOscan - a high throughput, quantitative ligand binding platform identifies best-in-class bromodomain inhibitors from a screen of mature compounds targeting other protein classes.

32. Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases

34. Discovery of Highly Potent and Selective Pan-Aurora Kinase Inhibitors with Enhanced in Vivo Antitumor Therapeutic Index

35. Comprehensive analysis of kinase inhibitor selectivity

37. A quantitative analysis of kinase inhibitor selectivity

38. Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680

41. A small molecule–kinase interaction map for clinical kinase inhibitors

50. Fast folding mutants of the Tetrahymenagroup I ribozyme reveal a rugged folding energy landscape11Edited by D. Draper

Catalog

Books, media, physical & digital resources